AIM ImmunoTech Inc. financial data

Symbol
AIM on NYSE, AIMI on OTC
Location
Ocala, FL
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 17 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 31% % -74%
Debt-to-equity -238% % -240%
Return On Equity 354% %
Return On Assets -257% % -74%
Operating Margin -13006% % 11%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2,853,114 shares -96%
Common Stock, Shares, Outstanding 2,764,188 shares -95%
Entity Public Float $20,793,354 USD -35%
Common Stock, Value, Issued $3,000 USD -95%
Weighted Average Number of Shares Outstanding, Basic 2,093,446 shares 263%
Weighted Average Number of Shares Outstanding, Diluted 2,093,446 shares 263%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $112,000 USD -41%
Revenue from Contract with Customer, Excluding Assessed Tax $112,000 USD -41%
Research and Development Expense $4,525,000 USD -41%
General and Administrative Expense $10,059,000 USD -51%
Costs and Expenses $14,679,000 USD -48%
Operating Income (Loss) $14,567,000 USD 48%
Net Income (Loss) Attributable to Parent $15,750,000 USD 34%
Earnings Per Share, Basic 6 USD/shares
Earnings Per Share, Diluted 6 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $2,347,000 USD 157%
Marketable Securities, Current $62,000 USD -99%
Assets, Current $2,575,000 USD -66%
Property, Plant and Equipment, Net $80,000 USD -32%
Operating Lease, Right-of-Use Asset $436,000 USD -33%
Other Assets, Noncurrent $362,000 USD -87%
Assets $5,494,000 USD -60%
Accounts Payable, Current $1,252,000 USD -80%
Employee-related Liabilities, Current $17,000 USD 1600%
Accrued Liabilities, Current $679,000 USD -33%
Liabilities, Current $4,043,000 USD -60%
Operating Lease, Liability, Noncurrent $226,000 USD -48%
Liabilities $11,571,000 USD 8.4%
Retained Earnings (Accumulated Deficit) $436,611,000 USD -3.7%
Stockholders' Equity Attributable to Parent $6,077,000 USD -309%
Liabilities and Equity $5,494,000 USD -60%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $2,361,000 USD 51%
Net Cash Provided by (Used in) Financing Activities $660,000 USD -77%
Net Cash Provided by (Used in) Investing Activities $898,000 USD
Common Stock, Shares Authorized 350,000,000 shares 0%
Common Stock, Shares, Issued 2,764,188 shares -95%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $803,000 USD 63%
Deferred Tax Assets, Valuation Allowance $42,879,000 USD 16%
Deferred Tax Assets, Gross $42,879,000 USD 12%
Operating Lease, Liability $458,000 USD -32%
Depreciation $10,000 USD 11%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $17,320,000 USD 40%
Property, Plant and Equipment, Gross $1,466,000 USD -5.7%
Operating Lease, Liability, Current $232,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Two $159,000 USD -35%
Lessee, Operating Lease, Liability, to be Paid, Year One $258,000 USD -6.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $30,000 USD -66%
Lessee, Operating Lease, Liability, to be Paid, Year Three $159,000 USD -20%
Deferred Tax Assets, Operating Loss Carryforwards $29,001,000 USD 15%
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Additional Paid in Capital $430,531,000 USD 1.6%
Amortization of Intangible Assets $48,000 USD -2%
Share-based Payment Arrangement, Expense $0 USD -100%
Interest Expense $553,000 USD -27%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%